Synthesis and in vitro antibacterial activity of N-[5-(5-nitro-2-furyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolone derivatives

Pharmazie

Volumn 58, Issue 6, 2003, Pages 432-433

  Foroumadi, A ^a,b   Ashraf Askari, R ^a   Moshafi, M H ^a   Emami, S ^a   Zeynali, A ^a  

^a Faculty of Pharmacy   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

1 CYCLOPROPYL 6 FLUORO 7 [4 [5 (5 NITRO 2 FURYL) 1,3,4 THIADIAZOL 3 YL] 1 PIPERAZINYL] 4 OXO 1,4 DIHYDRO 3 QUINOLONE CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 7 [4 [5 (5 NITRO 2 FURYL) 1,3,4 THIADIAZOL 2 YL] 1 PIPERAZINYL] 4 OXO 1,4 DIHYDRO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 7 [4 [5 (5 NITRO 2 FURYL) 1,3,4 THIADIAZOL 2 YL] 1 PIPERAZINYL] 4 OXO 1,4 DIHYDRO 3 QUINOLONE CARBOXYLIC ACID; CIPROFLOXACIN; ENOXACIN; N [5 (5 NITRO 2 FURYL) 1,3,4 THIADIAZOL 2 YL]PIPERAZINYLQUINOLONE DERIVATIVE; NORFLOXACIN; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION;

ANTI-INFECTIVE AGENTS; BACTERIA; INDICATORS AND REAGENTS; MICROBIAL SENSITIVITY TESTS; PIPERAZINES; QUINOLONES;

EID: 0038746697     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mascellino, M. T.; Farinellis, S.; Iegri, F.; Iona, E.; De Simone, C.: Drug Exptl. Clin. Res. 24, 139 (1998)
2. Fang, K. C.; Chen, Y. L.; Wang, T. C.; Tzeng, C. C.: J. Med. Chem. 43, 3809 (2000)
3. Cooper, C. S.; Tufano, M. D.; Donner, P. K.; Chu, D. T.: Bioorg. Med. Chem. 4, 1307 (1996)
4. Andriole, V. T.: Drugs 2, 1 (1999)
5. Hooper, D. C.: Clin. Infect. Dis. 32, Supp. 1: 59 (2001)
6. Domagala, J. M.; Hanna, L. D.; Heifetz, C. L.; Hutt, M. P.; Mich, T. F.; Sanchez, J. P.; Solomon, M.: J. Med. Chem. 29, 394 (1986)
7. Shen, L. L.; Mitscher, L. A.; Sharma, P. N.; O'Donnell, T. G.; Chu, D. W. T.; Cooper, C. S.; Rosen, T.; Pernet, A. G.: Biochemistry 28, 3886 (1989)
8. Foroumadi, A.; Emami, S.; Davood, A.; Moshafi, M. H.; Sharifian, A.; Tabatabaie, M.; Tarhimi-Farimani, H.; Sepehri, G.; Shafiee, A.: Pharm. Sci. 3, 559 (1997)
9. Foroumadi, A.; Davood, A.; Mirzaei, M.; Emami, S.; Moshafi, M. H.: Boll. Chim. Farm. 140, 411 (2001)
10. Momolo, M. G.; Vio, L.; Banfi, E.: Farmaco 51, 71 (1996)
11. Rollas, S.; Karakus, S.; Drugun, B. B.; Kiraz, M.; Erdeniz, H.: Farmaco 51, 811 (1996)
12. El-Dine, S. A.; Jawad, F. H.; Mahmoud, N. F.: Pharmazie 39, 101 (1984)
13. Hardman, J. G.; Limbird, L. E.; Molinoff, P. B.; Ruddon, R. W.: Goodman and Gilman's the pharmacological Basis of Therapeutics. 9. Ed., p. 1069, McGraw-Hill, New York (1996)
14. Foroumadi, A.; Daneshtalab, M.; Shafiee, A.: Arzneim-Forsch./Drug. Res. 49, 1035 (1999)
15. Hooper, D. C.; Wolfson, J. S.; Quinolone Antimicrobial Agents. 2nd Ed., P. 53, American Society for Microbiology, Washington D.C. (1993)